Aileron Therapeutics

Aileron Terminates Phase 1b Breast Cancer Chemoprotection Trial Of ALRN-6924
NASDAQ
Tue, 02/21/23 - 04:34 pm
Aileron Therapeutics
clinical trials
breast cancer
ALRN-6924
The Week Ahead In Biotech: Spotlight On ESMO Conference
Yahoo/Benzinga
Sun, 09/22/19 - 11:10 pm
JNJ
daratumumab
Urogen
Rhythm Pharmaceuticals
Anavex
Aravive Biologics
TrovaGene
Incyte
AstraZeneca
Roche
Amgen
Aslan
G1 Therapeutics
GSK
Calithera Biosciences
Seattle Genetics
Immunomedics
Checkpoint Therapeutics
Aileron Therapeutics
Genocea Biosciences
AbbVie
Zymeworks